<DOC>
	<DOC>NCT00355056</DOC>
	<brief_summary>The Purpose of this study is to evaluate the impact of percutaneous closure of a patent foramen ovale (a hole in the heart), using the AMPLATZER PFO Occluder, on the incidence of migraine headaches.</brief_summary>
	<brief_title>Premium Migraine Trial</brief_title>
	<detailed_description>The objective of this study is to evaluate whether percutaneous PFO closure is effective in reducing the incidence of disabling migraine headaches in patients who are refactory to medical treatment.</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Foramen Ovale, Patent</mesh_term>
	<criteria>Subjects diagnosed as having migraine headaches both with and without aura Have a Patent Foramen Ovale (PFO) A migraine history and show a refractoriness to medical treatment Willing to participate in followup visits Subjects whose primary headaches are other than migraine headaches Who overuse migraine treatments With a clinical history of stroke or Transient Ischemic Attack (TIA) With contraindication to aspirin therapy and Clopidogrel Pregnant or desire to become pregnant within the next year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Migraine</keyword>
	<keyword>PFO</keyword>
	<keyword>Migraine Headache</keyword>
	<keyword>patent foramen ovale</keyword>
</DOC>